Purpose
Advance healthcare professionals' knowledge of von Willebrand Disease (VWD) and improve patient outcomes through individualized therapy
Target Audience
This activity meets the needs of physicians and pharmacists involved in the care of patients with VWD
Program Overview
To facilitate best practices in the treatment of patients with VWD, it is important to highlight the integral role of the
hemostasis pharmacist and how he or she works collectively with the multidisciplinary care team.
This activity will provide a detailed overview of the disorder including proper diagnosis, available therapeutic approaches, options, and situation uses (in-demand, preop and postop surgery, and prophylaxis), pharmacokinetics, dosing, monitoring, and administration. It will also describe best practices and discuss the role of the pharmacist in the hospital, hemophilia treatment center, and home-care setting.
Educational Objectives
Upon completion of this activity, participants should be better able to:
- Recount an in-depth overview of VWD
- Review methods of diagnosis and current therapy options
- Describe best practices in the treatment of VWD
- Explain the role of the pharmacist involved in the treatment of patients with VWD
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Postgraduate Institute for Medicine (PIM) and ProMed Institute. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
PIM designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 Pharmacist Accreditation Statement
PIM is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
PIM designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Program Number - 809-999-07-070-L01)
Faculty Disclosure Statement
All faculty participating in continuing education activities sponsored by the Postgraduate Institute for Medicine are expected to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations/materials.
|
|
Original airdates: June 28, July 11, and
July 17, 2007
Expiration date: February 2010
Estimated time to complete activity: 1 hour
Login or register to access this activity.
Agenda
5 minutes—Welcome and Introduction
10 minutes—Overview of Disease State, Diagnosis, and Therapeutic Approaches
10 minutes—Available Therapies
10 minutes—Dosing, Monitoring, and Administration
10 minutes—The Pharmacist's Role
10 minutes—Question and Answer (Panel)
5 minutes—Closing Remarks
|
|
If your institution is interested in coordinating a Lunch-N-Learn to access this archive, contact ProMed Institute at 1-800-229-9590.
E-MAIL THIS PAGE TO A FRIEND
|
|
